Share on LinkedInShare on LinkedIn

ARTICLE · 11 FEBRUARY 2016

Changes At PMPRB To Safeguard Against Excessively Priced Medicines

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

Over the course of the next three years, PMPRB is seeking to change to its operations with the aim of becoming a more effective and stronger consumer protection agency.

CanadaIntellectual Property

Overview

Over the course of the next three years, PMPRB is seeking to change to its operations with the aim of becoming a more effective and stronger consumer protection agency.

According to its recently released Strategic Plan for 2015-2018, the PMPRB identified a number of challenges facing the PMPRB and Canadian consumers of pharmaceuticals. These include:  the emergence of extrinsic bodies engaging in price review, absence of publically funded universal drug coverage, and non-transparent, fragmented drug purchasing across the country.

In response, the PMPRB has proposed a number of changes to the way it carries out its regulatory and reporting functions, as well as its vision for regulatory reform. 

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from